Darwin Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
Darwin Advisors, LLC
- $356 Million
- Q3 2024
A detailed history of Darwin Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Darwin Advisors, LLC holds 35 shares of BMRN stock, worth $1,988. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35Holding current value
$1,988% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
670Shares Held
185MCall Options Held
1.22MPut Options Held
962K-
Black Rock Inc. New York, NY22.7MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$896 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$849 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$613 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...